Fiocruz Reasserts Partnership With AstraZeneca To Research Covid-19 Vaccine
On September 8th, it signed a technological order contract with AstraZeneca, which ensures access to 100.4 million doses of the active pharmaceutical ingredient for the vaccine's final processing, and also full technology transfer.
RIO DE JANEIRO, BRAZIL - After the University of Oxford announced on Saturday that it will resume trials of its Covid-19 vaccine, Fiocruz reasserted its partnership with Subscribe to our Premium Membership Plan. Already Subscribed? Login Here
The Rio Times is an English language publication dedicated to anyone interested in Brazil and Mercosur. Beyond keeping up with national and local events, The Rio Times will also cover issues of specific interest to foreign nationals here. Our mission is to provide our readers with a broad spectrum of information and improve their understanding of Rio de Janeiro, São Paulo, Brazil, and Mercosur.